Annual Operating Expenses:
$190.39M-$36.47M(-16.08%)Summary
- As of today, CPRX annual total operating expenses is $190.39 million, with the most recent change of -$36.47 million (-16.08%) on December 31, 2024.
- During the last 3 years, CPRX annual operating expenses has risen by +$123.82 million (+186.02%).
- CPRX annual operating expenses is now -16.08% below its all-time high of $226.86 million, reached on December 31, 2023.
Performance
CPRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$50.31M-$491.00K(-0.97%)Summary
- As of today, CPRX quarterly total operating expenses is $50.31 million, with the most recent change of -$491.00 thousand (-0.97%) on June 30, 2025.
- Over the past year, CPRX quarterly operating expenses has increased by +$6.59 million (+15.08%).
- CPRX quarterly operating expenses is now -57.08% below its all-time high of $117.22 million, reached on September 30, 2023.
Performance
CPRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CPRX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -16.1% | +15.1% |
| 3Y3 Years | +186.0% | +197.7% |
| 5Y5 Years | +241.7% | +231.3% |
CPRX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -16.1% | +186.0% | -57.1% | +168.2% |
| 5Y | 5-Year | -16.1% | +241.7% | -57.1% | +266.3% |
| All-Time | All-Time | -16.1% | >+9999.0% | -57.1% | >+9999.0% |
CPRX Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $50.31M(-1.0%) |
| Mar 2025 | - | $50.80M(+5.9%) |
| Dec 2024 | $190.39M(-16.1%) | $47.99M(-2.4%) |
| Sep 2024 | - | $49.16M(+12.5%) |
| Jun 2024 | - | $43.72M(-11.7%) |
| Mar 2024 | - | $49.52M(+12.5%) |
| Dec 2023 | $226.86M(+191.0%) | $44.01M(-62.5%) |
| Sep 2023 | - | $117.22M(+262.4%) |
| Jun 2023 | - | $32.35M(-2.8%) |
| Mar 2023 | - | $33.28M(+77.4%) |
| Dec 2022 | $77.97M(+17.1%) | $18.76M(-16.5%) |
| Sep 2022 | - | $22.48M(+33.0%) |
| Jun 2022 | - | $16.90M(-14.8%) |
| Mar 2022 | - | $19.83M(+8.9%) |
| Dec 2021 | $66.56M(+9.6%) | $18.22M(+9.5%) |
| Sep 2021 | - | $16.64M(+4.1%) |
| Jun 2021 | - | $15.98M(+1.6%) |
| Mar 2021 | - | $15.72M(-10.3%) |
| Dec 2020 | $60.73M(+9.0%) | $17.53M(+27.6%) |
| Sep 2020 | - | $13.73M(-9.5%) |
| Jun 2020 | - | $15.18M(+6.3%) |
| Mar 2020 | - | $14.29M(-19.4%) |
| Dec 2019 | $55.72M(+57.9%) | $17.72M(+39.9%) |
| Sep 2019 | - | $12.66M(-6.9%) |
| Jun 2019 | - | $13.61M(+16.2%) |
| Mar 2019 | - | $11.71M(-23.6%) |
| Dec 2018 | $35.30M(+89.4%) | $15.33M(+87.6%) |
| Sep 2018 | - | $8.17M(+29.2%) |
| Jun 2018 | - | $6.33M(+6.8%) |
| Mar 2018 | - | $5.93M(+7.6%) |
| Dec 2017 | $18.63M(-0.0%) | $5.50M(+28.2%) |
| Sep 2017 | - | $4.29M(+3.0%) |
| Jun 2017 | - | $4.17M(-10.7%) |
| Mar 2017 | - | $4.67M(+8.5%) |
| Dec 2016 | $18.64M(-8.5%) | $4.30M(+10.2%) |
| Sep 2016 | - | $3.90M(-18.8%) |
| Jun 2016 | - | $4.81M(-22.8%) |
| Mar 2016 | - | $6.22M(+0.6%) |
| Dec 2015 | $20.36M | $6.19M(+23.6%) |
| Sep 2015 | - | $5.01M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $4.89M(+14.1%) |
| Mar 2015 | - | $4.28M(+7.7%) |
| Dec 2014 | $14.56M(+41.6%) | $3.98M(-3.1%) |
| Sep 2014 | - | $4.10M(+37.5%) |
| Jun 2014 | - | $2.98M(-14.8%) |
| Mar 2014 | - | $3.50M(+29.7%) |
| Dec 2013 | $10.29M(+97.5%) | $2.70M(-16.6%) |
| Sep 2013 | - | $3.24M(+22.4%) |
| Jun 2013 | - | $2.65M(+55.3%) |
| Mar 2013 | - | $1.71M(+13.5%) |
| Dec 2012 | $5.21M(-13.7%) | $1.50M(+17.3%) |
| Sep 2012 | - | $1.28M(+20.3%) |
| Jun 2012 | - | $1.06M(+67.0%) |
| Mar 2012 | - | $637.40K(-68.5%) |
| Dec 2011 | $6.04M(+33.8%) | $2.03M(+80.4%) |
| Sep 2011 | - | $1.12M(-18.4%) |
| Jun 2011 | - | $1.38M(-9.0%) |
| Mar 2011 | - | $1.51M(+24.5%) |
| Dec 2010 | $4.51M(-38.0%) | $1.21M(+33.7%) |
| Sep 2010 | - | $908.50K(-31.9%) |
| Jun 2010 | - | $1.33M(+26.9%) |
| Mar 2010 | - | $1.05M(-10.2%) |
| Dec 2009 | $7.28M(-33.2%) | $1.17M(-9.5%) |
| Sep 2009 | - | $1.29M(-26.9%) |
| Jun 2009 | - | $1.77M(-41.9%) |
| Mar 2009 | - | $3.04M(-19.7%) |
| Dec 2008 | $10.89M(+116.7%) | $3.79M(+30.1%) |
| Sep 2008 | - | $2.91M(+18.3%) |
| Jun 2008 | - | $2.46M(+42.9%) |
| Mar 2008 | - | $1.72M(+51.9%) |
| Dec 2007 | $5.03M(+73.2%) | $1.13M(+19.4%) |
| Sep 2007 | - | $950.40K(-33.9%) |
| Jun 2007 | - | $1.44M(-4.0%) |
| Mar 2007 | - | $1.50M(+69.1%) |
| Dec 2006 | $2.90M(+59.3%) | $885.20K(-34.0%) |
| Sep 2006 | - | $1.34M(+276.0%) |
| Jun 2006 | - | $357.00K |
| Dec 2005 | $1.82M(+235.6%) | - |
| Dec 2004 | $543.00K(+25.0%) | - |
| Dec 2003 | $434.30K(+69.7%) | - |
| Dec 2002 | $255.90K | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of CPRX is $190.39M
What is the all-time high annual operating expenses for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual total operating expenses is $226.86M
What is Catalyst Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, CPRX annual total operating expenses has changed by -$36.47M (-16.08%)
What is Catalyst Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of CPRX is $50.31M
What is the all-time high quarterly operating expenses for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $117.22M
What is Catalyst Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, CPRX quarterly total operating expenses has changed by +$6.59M (+15.08%)